[2-(乙基磺酰基)苯基]硼酸 | 1042443-60-6

• 物质功能分类: 化学试剂 - 有机试剂 - 硼酸
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: [2-(乙基磺酰基)苯基]硼酸
• 中文别名: 2-乙磺酸基苯硼酸
• 英文名称: 2-(ethylsulfonyl)phenylboronic acid
• 英文别名: 2-Ethylsulfonylphenylboronic acid；(2-ethylsulfonylphenyl)boronic acid
• CAS: 1042443-60-6
• 化学式: C₈H₁₁BO₄S
• 分子量: 214.05
• InChiKey: GNCPGKLAKBQXAU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.84
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  83
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  [2-(乙基磺酰基)苯基]硼酸 、 3-(4-bromo-2-chlorophenyl)-5-(1-(4-chlorophenyl)cyclobutyl)-4-methyl-4H-1,2,4-triazole 在 四(三苯基膦)钯 、 sodium carbonate 作用下， 以 乙醇 、 甲苯 为溶剂， 生成 3-[2-Chloro-4-(2-ethylsulfonylphenyl)phenyl]-5-[1-(4-chlorophenyl)cyclobutyl]-4-methyl-1,2,4-triazole
  参考文献：
  名称：

  4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I

  摘要：

  4-Methyl-5-phenyl-(1,2,4)-triazoles were identified as selective inhibitors of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1). They were active in vitro and in an in vivo mouse pharmacodynamic (PD) model. The synthesis and structure activity relationships are presented. (c) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.04.013

文献信息

• Design and identification of a novel, functionally subtype selective GABA_Apositive allosteric modulator (PF-06372865).
  作者：Robert M. Owen、David C Blakemore、Lishuang Cao、Neil Flanagan、Rebecca Fish、Karl R Gibson、Rachel Gurrell、Chan Woo Huh、Juha Kammonen、Elisabeth Mortimer-Cassen、Sarah Nickolls、Kiyoyuki Omoto、Dafydd R Owen、Andrew Pike、David C. Pryde、David Reynolds、Rosemarie Roeloffs、Colin R. Rose、Clara Stead、Mifune Takeuchi、Joseph S Warmus、Christine Watson

  DOI：10.1021/acs.jmedchem.9b00322

  日期：——

  optimization, and evaluation of a series of novel imidazopyridazine-based subtype-selective positive allosteric modulators (PAMs) for the GABAA ligand-gated ion channel are described. From a set of initial hits multiple subseries were designed and evaluated based on binding affinity and functional activity. As designing in the desired level of functional selectivity proved difficult, a probability-based

  GABAA配体门控离子通道的一系列新型咪唑并哒嗪基亚型选择性正变构调节剂（PAM）的设计，优化和评估。从一组初始命中物中，设计了多个亚系列，并根据结合亲和力和功能活性对其进行了评估。由于难以在所需的功能选择性水平上进行设计，因此进行了基于概率的评估，以将项目的工作重点放在单个子系列上，该子系列提供目标配置文件的可能性最大。这些努力最终导致从该亚系列中鉴定出两个候选物，这些候选物已进行到临床前安全性研究，随后又鉴定了临床候选物PF-06372865。
• [EN] MORPHOLINO SUBSTITUTED UREA DERIVATIVES AS MTOR INHIBITORS<br/>[FR] DÉRIVÉS D'URÉE SUBSTITUÉE PAR UN MORPHOLINO EN TANT QU'INHIBITEURS DE MTOR
  申请人：CELLZOME LTD

  公开号：WO2011107585A1

  公开（公告）日：2011-09-09

  The invention relates to compounds of formula (I) wherein X1, X2, R1 to R4, m, n have the meaning as cited in the description and the claims. Said compounds are useful as inhibitors of mTOR for the treatment or prophylaxis of mTOR related diseases and disorders. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments.

  该发明涉及式（I）的化合物，其中X1、X2、R1至R4、m、n的含义如描述和权利要求中所述。所述化合物可用作mTOR的抑制剂，用于治疗或预防与mTOR相关的疾病和紊乱。该发明还涉及包括所述化合物的药物组合物，以及这些化合物的制备和用作药物的用途。
• Copper-mediated peptide arylation selective for the N-terminus
  作者：Mary K. Miller、Haopei Wang、Kengo Hanaya、Olivia Zhang、Alex Berlaga、Zachary T. Ball

  DOI：10.1039/d0sc02933e

  日期：——

  paradigms exist for reactivity and selectivity in arylation of amine groups. This communication describes the utilization of boronic acid reagents bearing certain o-electron withdrawing groups for copper-mediated amine arylation of the N-terminus under mild conditions and primarily aqueous solvent. The method adds to the toolkit of boronic acid reagents for polypeptide modification under mild conditions

  多肽对化学方法提出了显着的选择性挑战。氨基在多肽结构中无处不在，但胺基芳基化的反应性和选择性的范例很少。该通讯描述了在温和条件和主要水溶剂下，利用带有某些邻电子吸电子基团的硼酸试剂进行铜介导的N末端胺芳基化。该方法添加到硼酸试剂工具包中，用于在温和条件下在水中进行多肽修饰，在赖氨酸侧链存在的情况下显示出对 N 末端的完全选择性。
• 4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I
  作者：Yuping Zhu、Steven H. Olson、Anne Hermanowski-Vosatka、Steven Mundt、Kashmira Shah、Marty Springer、Rolf Thieringer、Samuel Wright、Jianying Xiao、Hratch Zokian、James M. Balkovec

  DOI：10.1016/j.bmcl.2008.04.013

  日期：2008.6

  4-Methyl-5-phenyl-(1,2,4)-triazoles were identified as selective inhibitors of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1). They were active in vitro and in an in vivo mouse pharmacodynamic (PD) model. The synthesis and structure activity relationships are presented. (c) 2008 Elsevier Ltd. All rights reserved.